Abstract:Down syndrome (DS) is the most example of aneuploidy, resulting from an additional copy of all or part of chromosome 21. Competing endogenous RNAs (ceRNAs) play important roles in neuronal development and neurological defects. This study aimed to identify hub genes and synergistic crosstalk among ceRNAs in the DS fetal hippocampus as potential targets for the treatment of DS-related neurodegenerative diseases. We profiled differentially expressed long non-coding RNAs (DElncRNAs), differentially expressed circular RNAs (DEcircRNAs), differentially expressed microRNAs (DEmiRNAs), and differentially expressed messenger RNAs (DEmRNAs) in hippocampal samples from patients with or without DS. Functional enrichment analysis and gene set enrichment analysis were performed, and chromosome 21-related ceRNA and protein–protein interaction networks were constructed. Additionally, the correlations between lncRNA-mRNA and miRNA-mRNA expression in the samples and HEK293T cells were validated. Our finding of changes in the expression of some key genes and ncRNAs on chromosome 21 in DS might not fully conform to the gene dosage hypothesis. Moreover, we found that four lncRNAs ( MIR99AHG , PLCB4 , SNHG14 , GIGYF2 ) and one circRNA ( hsa_circ_0061697 ) may competitively bind with three miRNAs ( hsa-miR-548b-5p , miR-730-5p , and hsa-miR-548i ) and subsequently regulate five mRNAs ( beta-1,3-galactosyltransferase 5 [ B3GALT5 ], helicase lymphoid-specific [ HELLS ], thrombospondin-2 [ THBS2 ], glycinamide ribonucleotide transformylase [ GART ], clathrin heavy chain like 1 [ CLTCL1 ]). These RNAs, whether located on chromosome 21 or not, interact with each other and might activate the PI3K/Akt/mTOR and Wnt signaling pathways, which are involved in autophagosome formation and tau hyperphosphorylation, possibly leading to adverse consequences of trisomy 21. These findings provide researchers with a better understanding of the fundamental molecular mechanisms underlying DS-related progressive defects in neuronal development.

Abnormal MicroRNA Expression in Ts65Dn Hippocampus and Whole Blood: Contributions to Down Syndrome Phenotypes

Abnormal expression of microRNAs in the hippocampus of Ts65Dn mice]

Detection and Functional Annotation of Misregulated Micrornas in the Brain of the Ts65Dn Mouse Model of Down Syndrome.

Human Chromosome 21 Orthologous Region on Mouse Chromosome 17 is a Major Determinant of Down Syndrome-Related Developmental Cognitive Deficits.

Single-nucleus RNA sequencing reveals cell type-specific transcriptome alterations of Down syndrome hippocampus using the Dp16 mouse model

RNA sequencing comprehensive analysis of the mRNA and long noncoding RNA expression profiles in Down syndrome fetuses

Competing Endogenous RNAs Crosstalk in Hippocampus: A Potential Mechanism for Neuronal Developing Defects in Down Syndrome

Overexpression of miR-99a in hippocampus leads to impairment of reversal learning in mice

Mirna-155 Upregulation and Complement Factor H Deficits in Down’s Syndrome

Intermediate Microglial Transcriptomic States in a Mouse Model of Down Syndrome

Down Syndrome Developmental Brain Transcriptome Reveals Defective Oligodendrocyte Differentiation and Myelination

Cognitive and molecular characterization of the Ts66Yah murine model of Down syndrome: deepening on hippocampal changes associated with genotype and aging

A Microrna Cluster (Let-7C, Mirna-99A, Mirna-125B, Mirna-155 and Mirna-802) Encoded at Chr21q21.1-Chr21q21.3 and the Phenotypic Diversity of Down's Syndrome (DS; Trisomy 21).

Analysis of adult cerebral cortex and hippocampus transcriptomes reveals unique molecular changes in the Ts1Cje mouse model of down syndrome

Hippocampal long-term potentiation suppressed by increased inhibition in the Ts65Dn mouse, a genetic model of Down syndrome

Increased hippocampal epigenetic age in the Ts65Dn mouse model of Down Syndrome

Investigating brain alterations in the Dp1Tyb mouse model of Down syndrome

Value of Cytopathologist‐performed Ultrasound‐guided Fine‐needle Aspiration As a Screening Test for Ultrasound‐guided Core‐needle Biopsy in Nonpalpable Breast Masses

Genome-wide expression analysis in Down syndrome: insight into immunodeficiency

The lncRNA Snhg11 , a new candidate contributing to neurogenesis, plasticity, and memory deficits in Down syndrome

Genome‐wide hypermethylation is closely associated with abnormal expression of genes involved in neural development in induced pluripotent stem cells derived from a Down syndrome mouse model